Search Results - "RANDLE, Henry W"

Refine Results
  1. 1

    Ergonomics in Office‐Based Surgery: A Survey‐Guided Observational Study by ESSER, ADAM C., KOSHY, JAMES G., RANDLE, HENRY W.

    Published in Dermatologic surgery (01-11-2007)
    “…BACKGROUND The practice of office‐based surgery is increasing in many specialties. OBJECTIVE Using Mohs surgery as a model, we investigated the role of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    The historical link between solid-organ transplantation, immunosuppression, and skin cancer by Randle, Henry W

    Published in Dermatologic surgery (01-04-2004)
    “…Skin cancers are more common in organ transplant recipients than in the general population. The objective of this study was establish the historical link…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Suntanning: differences in perceptions throughout history by Randle, H W

    Published in Mayo Clinic proceedings (01-05-1997)
    “…In ancient times, the sun was venerated as a source of life in some cultures. Scientifically, the relationship between vitamin D and sunlight and the…”
    Get more information
    Journal Article
  8. 8

    Complete Closure by Purse‐String Suture After Mohs Micrographic Surgery on Thin, Sun‐Damaged Skin by Romiti, Ricardo, Randle, Henry W.

    Published in Dermatologic surgery (01-11-2002)
    “…background. The purse‐string suture technique is useful for partial closure of surgical defects. objective. We demonstrated that 100% closure can often be…”
    Get full text
    Journal Article
  9. 9

    Eruptive Epidermoid Cysts Resulting from Treatment with Imiquimod by MARTY, CHELSY L, RANDLE, HENRY W, WALSH, JOHN S

    Published in Dermatologic surgery (01-07-2005)
    “…BACKGROUNDBecause of its unique mechanism of action and safety profile, imiquimod, a topical immune response modifier, is used for many benign and malignant…”
    Get full text
    Journal Article
  10. 10

    Skin Cancer in an Atomic Veteran: Cause or Coincidence? by Nelson, Kevin L., Randle, Henry W.

    Published in Dermatologic surgery (01-11-2003)
    “…Background. Some military personnel who were exposed to ionizing radiation during atomic weapons tests subsequently developed skin cancer, but the cause–effect…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Giant basal cell carcinoma (T3). Who is at risk? by Randle, H W, Roenigk, R K, Brodland, D G

    Published in Cancer (01-09-1993)
    “…Giant basal cell carcinomas can cause extensive local invasion and disfigurement. This study determines in whom giant basal cell carcinomas develop. Fifty…”
    Get more information
    Journal Article
  13. 13

    Reversibility of blue-gray cutaneous discoloration from amiodarone by Blackshear, J L, Randle, H W

    Published in Mayo Clinic proceedings (01-07-1991)
    “…A 45-year-old man had severe blue-gray cutaneous discoloration during amiodarone therapy for atrial fibrillation. Therefore, this drug regimen was…”
    Get more information
    Journal Article
  14. 14

    The Historical Link Between Solid‐Organ Transplantation, Immunosuppression, and Skin Cancer by Randle, Henry W.

    Published in Dermatologic surgery (01-04-2004)
    “…Background. Skin cancers are more common in organ transplant recipients than in the general population. Objective. The objective of this study was establish…”
    Get full text
    Journal Article
  15. 15

    Commentary by RANDLE, HENRY W.

    Published in Dermatologic surgery (01-02-2004)
    Get full text
    Journal Article
  16. 16
  17. 17

    Basal Cell Carcinoma Identification and Treatment of the High‐Risk Patient by RANDLE, HENRY W.

    Published in Dermatologic surgery (01-03-1996)
    “…BACKGROUND Some cutaneous basal cell carcinomas have a significant potential to recur, disfigure, and nietastasize. OBJECTIVE AND METHODS The identification…”
    Get full text
    Journal Article
  18. 18

    Eruptive Epidermoid Cysts Resulting from Treatment with Imiquimod by Marty, Chelsy L., Randle, Henry W., Walsh, John S.

    Published in Dermatologic surgery (01-07-2005)
    “…Background Because of its unique mechanism of action and safety profile, imiquimod, a topical immune response modifier, is used for many benign and malignant…”
    Get full text
    Journal Article
  19. 19

    Commentary by Randle, HENRY W

    Published in Dermatologic surgery (01-08-2003)
    Get full text
    Journal Article
  20. 20

    Commentary by Randle, HENRY W.

    Published in Dermatologic surgery (01-08-2003)
    Get full text
    Journal Article